agilebiotics.com
Open in
urlscan Pro
2a01:7c8:aac2:2ac:5054:ff:fec5:bf3c
Public Scan
Submitted URL: http://agilebiotics.com/
Effective URL: https://agilebiotics.com/
Submission: On November 15 via api from US — Scanned from NL
Effective URL: https://agilebiotics.com/
Submission: On November 15 via api from US — Scanned from NL
Form analysis 0 forms found in the DOM
Text Content
Skip to content * About us * Our focus * Team * Management board * External consultant * Advisory board * Investors * Drug pipeline * News * Contact Menu * About us * Our focus * Team * Management board * External consultant * Advisory board * Investors * Drug pipeline * News * Contact EMPOWERING ANTIBIOTIC DEVELOPMENT AGILeBiotics B.V. is an early-stage pharmaceutical company focusing on the development of novel antibiotics. ABOUT US! We are passionately translating innovation into novel antibacterials to treat patients infected by life-threatening hospital-acquired multidrug-resistant infections. LATEST NEWS AGILEBIOTICS CONTRIBUTES TO FIGHT AGAINST FUTURE PANDEMIC INFECTIONS (E.G. COVID-19) 7 April 2020 AGILEBIOTICS B.V. APPOINTS NEW CEO VICTOR SCHUT 6 April 2020 AGILEBIOTICS WON THE INVESTORS FORUM 2019 AT THE DUTCH LIFE SCIENCES CONFERENCE 28 November 2019 More news INVESTORS * * * * * COLLABORATORS * * * * * * ABOUT AGILeBiotics B.V. is a pharmaceutical company focusing on the development of novel antibiotics for the treatment of multi-drug resistant infections * * Linkedin LATEST NEWS AGILEBIOTICS CONTRIBUTES TO FIGHT AGAINST FUTURE PANDEMIC INFECTIONS (E.G. COVID-19) 7 April 2020 AGILEBIOTICS B.V. APPOINTS NEW CEO VICTOR SCHUT 6 April 2020 AGILEBIOTICS WON THE INVESTORS FORUM 2019 AT THE DUTCH LIFE SCIENCES CONFERENCE 28 November 2019 AGILEBIOTICS HAS BEEN AWARDED THE EUSMI-H2020 GRANT FOR UP-SCALE SYNTHESIS OF PRE-CLINICAL ANTIBIOTIC CANDIDATE TOFRAMICIN 14 October 2019 COPYRIGHT © 2018 AGILEBIOTICS | ALL RIGHTS RESERVED. | WEBDEVELOPMENT SKITTER